Helicobacter Pylori Antikörper (FITC)

Produktnummer ABIN112965

Produktdetails anti-Helicobacter Pylori Antikörper (FITC)

Target: Helicobacter Pylori (H. pylori)

Reaktivität: Helicobacter pylori

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Helicobacter Pylori Antikörper ist konjugiert mit FITC

Applikation: Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)

Aufreinigung: Protein A affinity chromatography.

Immunogen: ATTC strain 43504.

Anwendungsinformationen

Applikationshinweise: Immunohistochemistry (formalin-fixed paraffin embedded). ELISA (> 1/5,000). Immunofluorescence microscopy (> 1/1,000). Acetone fixation of the antigen source is recommended prior to staining. Enzyme amplification following reaction with FITC conjugate can also be accomplishedutilizing enzyme-antibody conjugates specific to FITC.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 4-5 mg/mL (OD280 nm, E0.1%= 1.4)

Buffer: 0.01 M PBS, pH 7.2, containing 10 mg/mL BSA as stabilizer and 0.09 % Sodium Azide as preservative.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: -20 °C

Details zu Helicobacter Pylori

Target: Helicobacter Pylori (H. pylori)

Andere Bezeichnung: Helicobacter Pylori (H. pylori Produkte)

Substanzklasse: Virus

Hintergrund: The spiral shaped bacterium Helicobacter pylori is strongly associated with inflammation of the stomach and is also implicated in the development of gastric malignancy. H. pylori is known to cause peptic ulcers and chronic gastritis in human. It is associated with duodenal ulcers and may be involved in development of adenocarcimona and low-grade lymphoma of mucosa associated lymphoid tissue in the stomach. More recently this bacterium has also been implicated with a number of vascular disorders including heart disease. It is not clear how H. pylori is transmitted or why some patients become symptomatic while others do not. The bacteria are most likely spread from person to person through fecal-to-oral or oral-to-oral routes. Possible environmental reservoirs include contaminated water sources.Synonyms: H. pylori